These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25251069)

  • 41. Drug Screening Platforms and RPPA.
    Dawson JC; Warchal SJ; Carragher NO
    Adv Exp Med Biol; 2019; 1188():203-226. PubMed ID: 31820390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fragment-based lead discovery on G-protein-coupled receptors.
    Visegrády A; Keserű GM
    Expert Opin Drug Discov; 2013 Jul; 8(7):811-20. PubMed ID: 23621346
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug discovery through stem cell-based organoid models.
    Ranga A; Gjorevski N; Lutolf MP
    Adv Drug Deliv Rev; 2014 Apr; 69-70():19-28. PubMed ID: 24582599
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Organs-on-a-chip: a new tool for drug discovery.
    Polini A; Prodanov L; Bhise NS; Manoharan V; Dokmeci MR; Khademhosseini A
    Expert Opin Drug Discov; 2014 Apr; 9(4):335-52. PubMed ID: 24620821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Advances in zebrafish chemical screening technologies.
    Mathias JR; Saxena MT; Mumm JS
    Future Med Chem; 2012 Sep; 4(14):1811-22. PubMed ID: 23043478
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Connecting Parkinson's disease and drug addiction: common players reveal unexpected disease connections and novel therapeutic approaches.
    Gramage E; Herradón G
    Curr Pharm Des; 2011; 17(5):449-61. PubMed ID: 21375485
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Advances in microfluidics for drug discovery.
    Lombardi D; Dittrich PS
    Expert Opin Drug Discov; 2010 Nov; 5(11):1081-94. PubMed ID: 22827746
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fragment-based approaches to anti-HIV drug discovery: state of the art and future opportunities.
    Huang B; Kang D; Zhan P; Liu X
    Expert Opin Drug Discov; 2015 Dec; 10(12):1271-81. PubMed ID: 26372893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advantages of cell-based high-volume screening assays to assess nuclear receptor activation during drug discovery.
    Pinne M; Raucy JL
    Expert Opin Drug Discov; 2014 Jun; 9(6):669-86. PubMed ID: 24819724
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does drug abuse beget drug abuse? Behavioral analysis of addiction liability in animal models of prenatal drug exposure.
    Malanga CJ; Kosofsky BE
    Brain Res Dev Brain Res; 2003 Dec; 147(1-2):47-57. PubMed ID: 14741750
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Streamlining drug discovery assays for cardiovascular disease using zebrafish.
    Pott A; Rottbauer W; Just S
    Expert Opin Drug Discov; 2020 Jan; 15(1):27-37. PubMed ID: 31570020
    [No Abstract]   [Full Text] [Related]  

  • 52. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
    Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
    J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phenotypic screening approaches for Chagas disease drug discovery.
    Chatelain E; Ioset JR
    Expert Opin Drug Discov; 2018 Feb; 13(2):141-153. PubMed ID: 29235363
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epigenetics and memory: causes, consequences and treatments for post-traumatic stress disorder and addiction.
    Pizzimenti CL; Lattal KM
    Genes Brain Behav; 2015 Jan; 14(1):73-84. PubMed ID: 25560936
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Microglial alterations induced by psychoactive drugs: A possible mechanism in substance use disorder?
    Catale C; Bussone S; Lo Iacono L; Carola V
    Semin Cell Dev Biol; 2019 Oct; 94():164-175. PubMed ID: 31004753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Affinity-based screening techniques: their impact and benefit to increase the number of high quality leads.
    Bergsdorf C; Ottl J
    Expert Opin Drug Discov; 2010 Nov; 5(11):1095-107. PubMed ID: 22827747
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progress in developing D3 dopamine receptor ligands as potential therapeutic agents for neurological and neuropsychiatric disorders.
    Luedtkea RR; Mach RH
    Curr Pharm Des; 2003; 9(8):643-71. PubMed ID: 12570797
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Computational modeling in melanoma for novel drug discovery.
    Pennisi M; Russo G; Di Salvatore V; Candido S; Libra M; Pappalardo F
    Expert Opin Drug Discov; 2016 Jun; 11(6):609-21. PubMed ID: 27046143
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.